ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,176Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 337

$342K Total Retail Price of All Prescriptions

Rank: 137 out of 337

385 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 7,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 499 490 1 2
ATORVASTATIN CALCIUM 430 395 2 7
AMLODIPINE BESYLATE 423 397 3 3
LEVOTHYROXINE SODIUM 418 404 4 5
OMEPRAZOLE 330 305 5 4
SIMVASTATIN 321 321 6 1
METOPROLOL TARTRATE 310 295 7 6
FUROSEMIDE 259 253 8 8
HYDROCHLOROTHIAZIDE 239 225 9 9
ATENOLOL 212 204 10 10
ALENDRONATE SODIUM 182 181 11 19
LOSARTAN POTASSIUM 154 153 12 15
DIOVAN 150 150 13 26
HYDROCODONE-ACETAMINOPHEN 149 91 S3 14 13
QUINAPRIL HCL 130 109 15 50
LIPITOR 120 109 16 33
TRIAMTERENE-HCTZ 119 109 17 39
ALLOPURINOL 109 105 18 28
CITALOPRAM HBR 103 100 19 17
METFORMIN HCL 94 79 20 12
VERAPAMIL ER 80 78 21 77
WARFARIN SODIUM 78 77 22 11
METOPROLOL SUCCINATE 77 77 23 21
GEMFIBROZIL 76 76 24 114
METFORMIN HCL ER 75 67 25 52
FLUOXETINE HCL 65 51 26 57
ZOLPIDEM TARTRATE 64 56 27 23
DIOVAN HCT 60 60 28 88
AMITRIPTYLINE HCL 59 44 R 29 75
GLYBURIDE 58 51 R 30 53
AZITHROMYCIN 56 51 31 51
CLOPIDOGREL 55 55 32 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.